Does Dr. SINA EMAMI have financial conflicts of interest?

Dr. SINA EMAMI (MD) has received a total of $774 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $774 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. SINA EMAMI?

According to CMS Open Payments data, Dr. SINA EMAMI received funding from BOEHRINGER INGELHEIM PHARMACEUTICALS ($156), CALLIDITAS THERAPEUTICS US ($137), and AURINIA PHARMA U.S ($125).

Does Dr. SINA EMAMI receive research grants or speaking fees?

Dr. SINA EMAMI has received $774 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. SINA EMAMI

MDReal-Time Hydrated

Specialty: Internal Medicine, Nephrology

Practice Location: ENCINO, CA 91436

NPI Number: 1689954513

LIFETIME INDUSTRY VALUE

$774

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. EMAMI is a verified Internal Medicine, Nephrology practitioner based in ENCINO, CA.

Between 2021 and 2025, Dr. EMAMI had an overall industry promotional and research financial footprint of $774 as recorded in the federal CMS Open Payments database.

$774 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. EMAMI's primary funding source is BOEHRINGER INGELHEIM PHARMACEUTICALS, which accounts for $156 (representing 20.1% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 1

$156

20.1%

CALLIDITAS THERAPEUTICS US

Rank 2

$137

17.7%

AURINIA PHARMA U.S

Rank 3

$125

16.1%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.